Royal Bank of Canada’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,100
Closed -$2K 6746
2024
Q3
$2K Sell
1,100
-2,321
-68% -$4.22K ﹤0.01% 6202
2024
Q2
$18K Buy
3,421
+2,103
+160% +$11.1K ﹤0.01% 5733
2024
Q1
$7K Sell
1,318
-1,682
-56% -$8.93K ﹤0.01% 5912
2023
Q4
$23K Buy
3,000
+2,058
+218% +$15.8K ﹤0.01% 5725
2023
Q3
$4K Sell
942
-559
-37% -$2.37K ﹤0.01% 6186
2023
Q2
$5K Buy
1,501
+1,249
+496% +$4.16K ﹤0.01% 6235
2023
Q1
$1K Buy
252
+245
+3,500% +$972 ﹤0.01% 6564
2022
Q4
$0 Sell
7
-29
-81% ﹤0.01% 7252
2022
Q3
$0 Sell
36
-17
-32% ﹤0.01% 7382
2022
Q2
$0 Sell
53
-301
-85% ﹤0.01% 7212
2022
Q1
$4K Sell
354
-896
-72% -$10.1K ﹤0.01% 6858
2021
Q4
$40K Buy
1,250
+762
+156% +$24.4K ﹤0.01% 5969
2021
Q3
$22K Buy
488
+94
+24% +$4.24K ﹤0.01% 6141
2021
Q2
$21K Buy
394
+199
+102% +$10.6K ﹤0.01% 6042
2021
Q1
$15K Buy
195
+69
+55% +$5.31K ﹤0.01% 6111
2020
Q4
$14K Sell
126
-1,000
-89% -$111K ﹤0.01% 5686
2020
Q3
$100K Buy
1,126
+519
+86% +$46.1K ﹤0.01% 4507
2020
Q2
$65K Buy
607
+589
+3,272% +$63.1K ﹤0.01% 4642
2020
Q1
$1K Sell
18
-134
-88% -$7.44K ﹤0.01% 6005
2019
Q4
$11K Buy
+152
New +$11K ﹤0.01% 5516
2019
Q1
Sell
-3
Closed 5978
2018
Q4
$0 Sell
3
-53
-95% ﹤0.01% 6182
2018
Q3
$6K Buy
56
+41
+273% +$4.39K ﹤0.01% 5602
2018
Q2
$2K Buy
+15
New +$2K ﹤0.01% 5694
2018
Q1
Sell
-3
Closed 6034
2017
Q4
$0 Sell
3
-104
-97% ﹤0.01% 6088
2017
Q3
$16K Buy
107
+105
+5,250% +$15.7K ﹤0.01% 5325
2017
Q2
$0 Sell
2
-58
-97% ﹤0.01% 5975
2017
Q1
$10K Buy
60
+36
+150% +$6K ﹤0.01% 5302
2016
Q4
$3K Buy
24
+14
+140% +$1.75K ﹤0.01% 5655
2016
Q3
$1K Buy
+10
New +$1K ﹤0.01% 5548